“We are moving into fall and winter, and that means there will be more stuff inside than outside,” Dr Anthony Fauci said Tuesday. during the Atlantic Festival. “Coming into this situation, I would have liked to see the baseline of where we are – the daily number of infections – go down, down and not get stuck between 30,000 and 40,000 a day.”
At least 22 states are now reporting an increase in new cases, most of which are in the heartland and in the Midwest. That number is a remarkable difference from last Monday, when only nine states reported an upward trend in cases. As of early Wednesday morning, seven states reported a drop in new cases, according to data from Johns Hopkins University.
The virus, still relentlessly in many American communities, is raising new alarms in states like Kentucky and Wisconsin, which have one of the highest Covid-19 positivity rates in the country, above 16%.
“This virus is deadly, it is real and it hurts, kills us,” Kentucky Gov. Andy Beshear said at a press conference on Tuesday. “And one day we lost 200,000… it looks like the cases are back on the rise.”
Covid-19 is the third leading cause of death in the United States, according to the CDC.
Still probably months away from a vaccine available, experts and public health officials argue that the best way to contain the virus is through universal mask wear and social distancing.
How did the students tariff in the middle of a pandemic
The increase in cases also comes after several colleges reported outbreaks on campus and many chose to move classes online. In the United States, more than 59,000 cases of Covid-19 have been reported among students and staff.
In North Carolina, university officials announced that UNC Charlotte would resume in-person teaching on October 1 after consulting with local health officials.
The university claims to have “de-densified” the dormitories and given each student an individual room, limited indoor gatherings to 10 people and taken several other measures to control infections.
In Vermont, Middlebury College announced that 22 students were expelled from the school’s campus following “significant violations of Covid-19 conduct” during the week.
The sanctioning of students includes the revocation of their housing privileges on campus and they will not be allowed to study, take courses or visit other students on campus, wrote Middlebury Dean of Students Derek Doucet in a statement.
Hoping to fuel the transmission of the virus by welcoming students back, many school districts across the country have also started the new school year with virtual education.
The Miami-Dade County School Board on Tuesday unanimously voted to reopen school buildings no earlier than October 14. A gradual opening will begin that day for the youngest kindergarten, kindergarten and first grade students and students with special needs. The district reopening will be completed on October 21, two weeks later than initially proposed by the superintendent.
Miami-Dade is the largest school district in the state and one of the largest in the country, with approximately 345,000 students and over 40,000 employees.
The school board’s decision comes after many public schools in Florida already reopened last month. Since then, the number of children under 18 who have contracted Covid-19 across Florida has jumped 26% in mid-September, according to state data.
New rules for vaccine approval?
In the meantime, the United States Food and Drug Administration is considering new rules for the authorization of a Covid-19 vaccine, according to three sources familiar with the situation.
Calculations show that these rules would push vaccine clearance beyond polling day. A source said the FDA should tell vaccine manufacturers that they must wait two months after giving all of their study participants their second doses of the vaccine until they can apply for an EUA.
Pfizer and Moderna, two companies that have started a Phase 3 clinical trial for coronavirus vaccines in the United States, have administered second doses to less than half of their participants.
Companies are also expected to start looking at children, who are “stuck in vaccine neutrality”, a group of doctors wrote in a comment on Friday.
“Even though things are moving at an unprecedented speed for adults and the elderly for Covid-19 vaccines, we have yet to make progress in launching pediatric trials,” said Dr Buddy Creech, specialist in pediatric infectious diseases at Vanderbilt University and an author of the commentary published in the medical journal Clinical Infectious Diseases.
A Pfizer spokesperson says the company is “actively working with regulators on a potential pediatric study plan.”
And Modern told CNN in a statement the company “shares the urgency” associated with the need to take a closer look at Covid-19 vaccines for children.
“Now that Moderna has sufficient safety data in adults, we plan to begin pediatric trials in the near future, subject to regulatory approval. “
CORRECTION: This story has been updated to correct the ranking of Covid-19 as a cause of death in the United States. This is the third, according to the CDC.
CNN’s Amanda Watts, Rob Frehse, Giovanna Van Leeuwen, Stephanie Gallman, John Bonifield, Andrea Kane, Denise Royal and Rosa Flores contributed to this report.